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Excisional procedures of cervical intraepithelial neoplasia (CIN) may increase the risk of pre-
term birth. It is unknown whether this increased risk is due to the excision procedure itself, to
the underlying CIN, or to secondary risk factors that are associated with both preterm birth
and CIN. The aim of this study is to assess the risk of spontaneous preterm birth in women
with treated and untreated CIN and examine possible associations by making a distinction
between the excised volume of cervical tissue and having cervical disease.
Methods and findings
This Dutch population-based observational cohort study identified women aged 29 to 41
years with CIN between 2005 and 2015 from the Dutch pathology registry (PALGA) and fre-
quency matched them with a control group without any cervical abnormality based on age at
and year of pathology outcome (i.e., CIN or normal cytology) and urbanization (<100,000
inhabitants or�100,000 inhabitants). All their 45,259 subsequent singleton pregnancies
with a gestational age�16 weeks between 2010 and 2017 were identified from the Dutch
perinatal database (Perined). Nineteen potential confounders for preterm birth were identi-
fied. Adjusted odds ratios (ORs) were calculated for preterm birth comparing the 3 different
groups of women: (1) women without CIN diagnosis; (2) women with untreated CIN; and (3)
women with treated CIN prior to each childbirth.
In total, 29,907, 5,940, and 9,412 pregnancies were included in the control, untreated
CIN, and treated CIN group, respectively. The control group showed a 4.8% (1,002/20,969)
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proportion of spontaneous preterm birth, which increased to 6.9% (271/3,940) in the
untreated CIN group, 9.5% (600/6,315) in the treated CIN group, and 15.6% (50/321) in the
group with multiple treatments. Women with untreated CIN had a 1.38 times greater odds of
preterm birth compared to women without CIN (95% confidence interval (CI) 1.19 to 1.60; P
< 0.001). For women with treated CIN, these odds 2.07 times increased compared to the
control group (95% CI 1.85 to 2.33; P < 0.001). Treated women had a 1.51 times increased
odds of preterm birth compared to women with untreated CIN (95% CI 1.29 to 1.76; P <
0.001). Independent from cervical disease, a volume excised from the cervix of 0.5 to 0.9 cc
increased the odds of preterm birth 2.20 times (37/379 versus 1,002/20,969; 95% CI 1.52 to
3.20; P < 0.001). These odds further increased 3.13 times and 5.93 times for women with an
excised volume of 4 to 8.9 cc (90/724 versus 1,002/20,969; 95% CI 2.44 to 4.01; P < 0.001)
and�9 cc (30/139 versus 1,002/20,969; 95% CI 3.86 to 9.13; P < 0.001), respectively. Limi-
tations of the study include the retrospective nature, lack of sufficient information to calculate
odds of preterm birth <24 weeks, and that the excised volume could only be calculated for a
select group of women.
Conclusions
In this study, we observed a strong correlation between preterm birth and a volume of�0.5
cc excised cervical tissue, regardless of the severity of CIN. Caution should be taken when
performing excisional treatment in women of reproductive age as well as prudence in case
of multiple biopsies. Fertile women with a history of performing multiple biopsies or exci-
sional treatment for CIN may benefit from close surveillance during pregnancy.
Author summary
Why was this study done?
• Women who are treated for a precancerous cervical lesion may have an increased risk of
preterm birth.
• It is unknown whether this increased risk is due to the treatment itself, to the cervical
disease, or to secondary risk factors that are associated with both preterm birth and cer-
vical disease.
What did the researchers do and find?
• We identified women with untreated and treated cervical disease and matched them
with a control group through the Dutch pathology registry and compared their preg-
nancy outcomes through the Dutch perinatal database.
• The control group (29,907 pregnancies) showed a 4.8% proportion of preterm birth,
which increased to 6.9% in the untreated cervical disease group (5,940 pregnancies),
9.5% in the treated cervical disease group (9,412 pregnancies), and 15.6% in the group
with multiple treatments (505 pregnancies).
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• After adjustment for 19 potential confounders for preterm birth, women with untreated
cervical disease had a 1.4 times and women with treated cervical disease had a more
than 2 times increased odds of preterm birth compared to the control group.
• Independent from cervical disease, a volume excised from the cervix of 0.5 cc or more
was associated with an approximately 2 times greater odds of preterm birth.
What do these findings mean?
• We observed a strong association between women with a 0.5 cc or more excised cervical
tissue volume (through biopsy and/or treatment) and the odds of preterm birth, regard-
less of severity of cervical disease or secondary risk factors associated with both preterm
birth and cervical disease.
• Our findings suggest that caution should be taken when performing multiple biopsies
or treatment for CIN in women of reproductive age and that women with such a history
may benefit from close surveillance during pregnancy.
Introduction
The introduction of cervical cancer screening programs has drastically decreased the incidence
and mortality from cervical cancer, due to early treatment of high-grade cervical intraepithelial
neoplasia (CIN) [1]. Women participating in the screening program may undergo biopsy or
treatment within their reproductive age, as the incidence of CIN peaks at around the age of 30.
Although women with a true risk of progression to cervical cancer (�CIN3) need treatment,
one should be conservative with excisional procedures if they have future pregnancy desires.
Research has shown that excisional procedures of CIN may increase the risk of adverse preg-
nancy outcomes, such as preterm birth, preterm premature rupture of membranes (pPROM),
and consequently less favorable neonatal outcomes as a direct result of prematurity [2–5].
Additionally, the number of excisional procedures and increasing cone depth further increase
the risk of preterm birth [5].
Screening programs are replacing primary cytology testing by primary high-risk human
papillomavirus (hrHPV) testing, resulting in higher referral rates and more women undergo-
ing biopsy or treatment [6], which may further increase the number of women at risk for
adverse pregnancy outcomes.
It is unknown whether the increased risk for preterm birth is due to the excision procedure
itself, to the underlying CIN, or to secondary risk factors that are associated with both preterm
birth and CIN. Literature shows conflicting results for the risk of preterm birth in treated
women versus untreated women with CIN [3–5,7]. A recent meta-analysis including 69 publi-
cations concluded that many studies were of low quality; they are small, do not compare
women in all 3 groups appropriately (women without a CIN diagnosis, with untreated CIN,
and treated CIN), or have only limited information about potential confounders [5]. Addition-
ally, as there are many reasons for premature induction of labor, it is important to identify
women with spontaneous preterm birth.
A large study is needed with a comparison between women without CIN diagnosis,
untreated CIN, and treated CIN, including adjustment for potential confounding factors. To
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examine the effect of diagnostic and therapeutic techniques, it is important to account for the
volume excised from the cervix for each biopsy and treatment.
Therefore, the first aim of this population-based study is to assess the risk of spontaneous
preterm birth in women with treated and untreated CIN compared to women without a CIN
diagnosis and to examine the correlation of preterm birth with the extent of excised volume
and having cervical disease, both adjusted for potential confounders. Secondly, the risk of
other adverse maternal and neonatal outcomes is assessed.
Methods
Women aged 29 to 41 years (including 3 screening invitations at age 30, 35, and 40) with a
CIN diagnosis or adenocarcinoma in situ between 2005 and 2015 were identified from the
Dutch pathology registry (PALGA) [8]. Only histologic outcomes of CIN obtained through
biopsy or cervical excisional treatment were included. Cytological outcomes or histological
outcomes diagnosed by hysterectomy, polypectomy, or endocervical curettage were excluded.
The date and result of each biopsy and/or treatment was reported. The size of the excised cervi-
cal tissue was extracted from the macroscopic description when available using pattern recog-
nition (length × width × depth) as recorded during laboratory processing. A maximum
volume of 4.5 cc and 27 cc was accepted as plausible for biopsy and treatment, respectively. A
frequency matched control group was identified from PALGA by selecting women with only
normal cervical cytology and no CIN diagnosis in their history. Matching was done by age at
and year of pathology outcome (i.e., CIN or normal cytology) and urbanization (<100,000
inhabitants or�100,000 inhabitants).
All singleton pregnancies with a gestational age�16 weeks between 2010 and 2017 were
identified from the Dutch perinatal database (Perined). This database links all medical regis-
tries from the 4 professional organizations that provide perinatal care in the Netherlands: the
Dutch Society of Obstetrics and Gynaecology (NVOG), the Royal Dutch Organisation of Mid-
wives (KNOV), the Dutch Association of Pediatrics (NVK), and the National Association of
General Practitioners (LHV). It contains detailed anonymized population-based information
(over 97% of all pregnancies in the Netherlands) on pregnancies, deliveries, and neonatal (re)
admissions [9].
The pseudonymized personal identifiers from PALGA and Perined were linked by Statistics
Netherlands (CBS) using a dedicated Privacy Verzend Module (PVM), designed by as trusted
third party (ZorgTTP). Unique women were given a new study number.
We used the gestational age of<37 weeks at birth for the primary outcome, spontaneous
preterm birth. We compared the date of CIN diagnosis and date of birth to select only preg-
nancies occurring after CIN detection with or without prior treatment. We subanalyzed pre-
term birth for<28 and<32 weeks. Secondary (maternal) outcomes were spontaneous
conception, threatened preterm birth, pPROM, assisted vaginal delivery, and cesarean section.
Primary cesarean section and secondary cesarean section because of abnormal fetal position
were excluded. Secondary (neonatal) outcomes were low birth weight (in grams and Hoftiezer
percentiles), appearance, pulse, grimace, activity, and respiration (APGAR) score <7 at 5 min-
utes, high care or intensive care admission, and perinatal death (period defined as between 22
weeks of gestation and�28 days postpartum). Women with induction of labor were excluded
for the outcomes of preterm birth, pPROM, and all neonatal outcomes. Ruptured membranes
>36 hours before induction of labor were identified as spontaneous rupture of membranes
and included in the analysis for pPROM. Risk factors for preterm birth were identified
through an extensive literature search and expert consultation and were regarded as potential
confounders. We identified age at childbirth, year of childbirth, ethnicity, diabetes mellitus,
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maternal infection, epilepsy, psychiatric diseases, history of abortion, history of preterm birth
(excluding women with prior cervical excisional treatment), pregnancy by in vitro fertilization
(IVF), nulliparous women, pre-eclampsia, gestational diabetes, placental abruption, placenta
or vasa previa, congenital diseases, intrauterine growth restriction, macrosomia, stillbirth, and
fetal distress as potential confounders for preterm birth. As these identified risk factors possi-
bly could influence the outcome measures by unequal distribution among the 3 groups or may
have an indirect association with having cervical disease, we chose to include all these potential
confounders in the multivariable analysis. Urbanization was also included in multivariable
analysis as the groups were composed differently when considering them per pregnancy
instead of per woman.
Binary logistic regression was used to calculate odds ratios (ORs) with 95% confidence
intervals (CIs). ORs were calculated for each outcome comparing the 3 different groups of
women: (1) women without CIN; (2) women with untreated CIN; and (3) women with treated
CIN. We also conducted a subanalysis for women with multiple excisional treatments.
Women who gave birth multiple times could be included more than once in analysis. The total
volume excised from the cervix (for example, the volume of the biopsy and following treatment
or multiple biopsies) and severity of cervical disease was used to examine the possible correla-
tions with preterm birth. We divided the volumes into quantiles and used trend analysis to
find the optimal balance of variance and amount. Finally, we clustered the quantiles together
into clinical relevant groups for the final regression. We considered different P values as statis-
tically significant to adjust for multiple testing. This was done by dividing the 0.05 P value
threshold by the number of tests done. All data preprocessing were performed through Python
programming language in Jupyter Notebook with the use of “Pandas” version 1.0.1 and
“NumPy” version 1.18.0 libraries (Python Software Foundation, version 3.7.4, https://www.
python.org/) [10,11]. All statistical analyses were performed in the statistical software package
SPSS 25.0 (IBM SPSS Statistics; New York, United States). The prospective analysis plan and
changes in the plan can be found in the supporting information (S1 Protocol). This study is
reported as per the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) guideline (S1 Checklist).
Ethics approval
All the authors report adherence to ethical standards in the conception of the work, data col-
lection, and writing of the manuscript. The study was approved by the scientific committee of
the Dutch pathology registry (PALGA) and the Dutch perinatal registry (Perined). The study
was exempt from institutional review board approval because data were gathered retrospec-
tively and analyzed anonymously. As both registries and Statistics Netherlands (CBS) protect
the anonymity of the included women and data were analyzed anonymously, their written
consent was not needed.
Patient and public involvement
Patients or the public were not involved in this study.
Results
We identified 50,721 cytological and histological results in PALGA that had been linked to
Perined. We excluded 321 misclassified outcomes and 112 histological outcomes obtained
through hysterectomy, polypectomy, or endocervical curettage. The included 50,288 outcomes
were from 39,036 women, which had 52,980 singleton pregnancies with a gestational age�16
weeks between 2010 and 2017. There were 7,721 pregnancies excluded, as they happened prior
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to the first CIN diagnosis. Eventually, 29,907 pregnancies were included in the control group,
5,940 pregnancies in the group of women with untreated CIN, and 9,412 pregnancies in the
group of women with treated CIN (S1 Fig).
The basic characteristics of each group are described in Table 1. About half of the women
in the untreated CIN group had CIN1, whereas more than 60% of the women had CIN3 in the
treated CIN group. In 16% and 52% of the cases, the volume excised from the cervix before
each childbirth could be determined in the untreated CIN and treated CIN group, respectively.
The median volume for biopsy was 0.84 cc (range 0.10 to 4.44), and for excisional treatment
2.40 cc (range 0.10 to 26.30). The median gestation at spontaneous birth was 39+6 or 40+0
weeks (range 17+0 to 43+4). Women with untreated and treated CIN gave birth on average
2.85 days (95% CI 2.44 to 3.26; P< 0.001) and 1.13 days (95% CI 0.70 to 1.57; P< 0.001) ear-
lier compared to women without CIN. Women with�2 times treated CIN gave birth on aver-
age 7.03 days (95% CI 4.81 to 9.25; P<0.001) earlier compared to women without CIN.
Table 1. Basic characteristics of women with no CIN, untreated CIN, and treated CIN before each childbirth.
No CIN n = 29,907 Untreated CIN n = 5,940 Treated CIN n = 9,412
Age of women at birth, years
Median (range) 33.0 (24–48) 34.0 (29–46) 34.0 (29–49)
Year of childbirth
Range 2010–2017 2010–2017 2010–2017
Urbanization, n (%)
<100,000 inhabitants 18,095 (60.5) 3,076 (51.8) 5,083 (54.0)
�100,000 inhabitants 11,812 (39.5) 2,864 (48.2) 4,329 (46.0)
Number of treatments, n (%)
1 NA NA 8,907 (94.6)
2 NA NA 461 (4.9)
�3 NA NA 44 (0.5)
Highest diagnosis, n (%)
CIN1 NA 3,037 (51.1) 651 (6.9)
CIN2 NA 1,593 (26.8) 2,684 (28.5)
CIN3 NA 1,268 (21.4AU : Pleasenotethattheindicatorshavebeenrearrangedalphabetically;movingdownwardinTable1;asperPLOSstyle; hence; thefootnoteshavebeenrearrangedaswell:Pleaseconfirmthatthesechangesarevalid:)a 5,865 (62.3)
AIS NA 31 (0.5)a 145 (1.5)
Cervical cancer NA 11 (0.2)a 67 (0.7)
Volume taken from cervix
n (%) NA 971 (16.3) 4,865 (51.7)
Mean (SD), cc NA 1.16 (1.06) 3.13 (2.78)
Median (range), cc NA 0.84 (0.10–4.44) 2.40 (0.10–26.30)
Gravidity
Median, (range) 2 (1–14) 2 (1–17) 2 (1–20)
Parity
Median (range) 1 (0–14) 1 (0–16) 1 (0–18)
Gestational age at birthb
n (%) 20,969 (70.1) 3,940 (66.3) 6,315 (67.1)
Median (range), weeks 40+0 (20+0 to 42+5) 39+6 (17+6 to 43+4) 39+6 (17+0 to 42+3)
aPatients could have been lost to follow-up or have received other forms of treatment without histologic results, such as radiotherapy, cryotherapy, electrocoagulation,
laser ablation, or a topical immune-response modulator.
bWomen with induction of labor were excluded from analysis.
Abbreviations: AIS, adenocarcinoma in situ; CIN, cervical intraepithelial neoplasia; NA, not applicable; SD, standard deviation.
https://doi.org/10.1371/journal.pmed.1003665.t001
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Preterm birth
Fig 1 shows the proportion of spontaneous births in women without CIN, with untreated CIN,
single treated CIN, and multiple treated CIN per gestational age. The risk of preterm birth
between these groups of women is shown in Table 2 (unadjusted analyses in S2 Table). Overall,
1,873 (6.0%), 228 (0.7%), and 85 (0.3%) women delivered their baby before 37, 32, and 28
weeks, respectively. The control group showed a 4.8% proportion of preterm birth<37 weeks,
which increased to 6.9% in the untreated CIN group, 9.5% in the treated CIN group, and
15.6% in the group with multiple treatments. After adjustment for all potential confounders
(age at childbirth, year of childbirth, urbanization, ethnicity, diabetes mellitus, maternal infec-
tion, epilepsy, psychiatric diseases, history of abortion, history of preterm birth, pregnancy by
IVF, nulliparous women, pre-eclampsia, gestational diabetes, placental abruption, placenta or
vasa previa, congenital diseases, intrauterine growth restriction, macrosomia, stillbirth, and
fetal distress), women with untreated CIN had a 1.38 times increased odds of preterm birth
compared to women without CIN (95% CI 1.19 to 1.60; P< 0.001). For women with treated
CIN, these odds were 2.07 times greater compared to the control group (95% CI 1.85 to 2.33;
P< 0.001). Treated women had a 1.51 times higher odds of preterm birth compared to
women with untreated CIN (95% CI 1.29 to 1.76; P< 0.001). The odds further increased for
women with multiple treatments (compared to the control group: OR 3.66; 95% CI 2.66 to
5.05; P< 0.001; compared to untreated CIN: OR 2.66; 95% CI 1.90 to 3.72; P< 0.001; and
compared to women with single treatment: OR 1.83; 95% CI 1.33 to 2.53; P< 0.001). No statis-
tically significant difference was found for preterm birth <32 and <28 weeks for women with
untreated CIN compared to women without CIN or treated CIN (<32 weeks untreated CIN
versus no CIN: OR 1.34; 95% CI 0.88 to 2.05; P = 0.18;<32 weeks treated CIN versus untreated
CIN: OR 1.72; 95% CI 1.12 to 2.65; P = 0.01; <28 weeks untreated CIN versus no CIN: OR
1.22; 95% CI 0.58 to 2.57; P = 0.60; and<28 weeks treated CIN versus untreated CIN: OR 2.09;
95% CI 0.99 to 4.40; P = 0.015). The odds of preterm birth<32 and<28 weeks remained sta-
tistically significantly increased for women with treated CIN compared to the control group
(OR 2.30; 95% CI 1.68 to 3.16; P< 0.001 and OR 2.55; 95% CI 1.50 to 4.35; P = 0.001,
Fig 1. Spontaneous births by gestational age for women with no CIN, untreated CIN, or treated CIN (treated CIN
1× or treated CIN�2×) before each childbirth. The distribution between all 4 groups was statistically significantly
different (all P< 0.001; two-sample Kolmogorov–Smirnov test). CIN, cervical intraepithelial neoplasia.
https://doi.org/10.1371/journal.pmed.1003665.g001
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respectively). The OR of preterm birth <32 and<28 weeks was the highest for women with
multiple treatments compared to women without CIN (OR 5.32; 95% CI 2.58 to 10.95;
P< 0.001 and OR 7.02; 95% CI 2.35 to 21.02; P< 0.001, respectively). The univariate logistic
regression analyses for preterm birth for the 19 potential confounders can be found in S1
Table.
Examining excision of cervical tissue and having cervical disease as possible
associations of preterm birth
Fig 2 shows the proportion of spontaneous births per gestational age stratified per volume
excised from the cervix. To distinguish if the increased odds for preterm birth in treated versus
untreated women with CIN are associated with the volume of the excised tissue or the severity
of cervical disease, we performed a multivariable logistic regression including these variables.
The odds of preterm birth remained significant with adjustment for severity of cervical disease
(OR 1.40; 95% CI 1.17 to 1.67; P< 0.001) but were no longer statistically significant after
adjustment for size of the excision (OR 1.22 95% CI 0.87 to 1.73; P = 0.25). Per 1 cc of excised
volume of the cervix women gave birth on average a half day earlier (Control group included:
Table 2. Multivariable logistic regression for preterm birth for women with no CIN, untreated CIN, and treated CIN before each childbirtha.
Primary outcome Event/total (%) OR (95% CI) P valuec
Preterm birth <37 weeksb 1,873/31,224 (6.0)
Untreated CIN vs no CIN 271/3,940 (6.9) 1,002/20,969 (4.8) 1.38 (1.19 to 1.60) <0.001�
Treated CIN vs no CIN 600/6,315 (9.5) 1,002/20,969 (4.8) 2.07 (1.85 to 2.33) <0.001�
Treated CIN vs untreated CIN 600/6,315 (9.5) 271/3,940 (6.9) 1.51 (1.29 to 1.76) <0.001�
Treated CIN�2× vs no CIN 50/321 (15.6) 1,002/20,969 (4.8) 3.66 (2.66 to 5.05) <0.001�
Treated CIN�2× vs untreated CIN 50/321 (15.6) 271/3,940 (6.9) 2.66 (1.90 to 3.72) <0.001�
Treated CIN�2× vs treated CIN 1× 50/321 (15.6) 550/5,994 (9.2) 1.83 (1.33 to 2.53) <0.001�
Preterm birth <32 weeksb 228/31,224 (0.7)
Untreated CIN vs no CIN 32/3,940 (0.8) 116/20,969 (0.6) 1.34 (0.88 to 2.05) 0.18
Treated CIN vs no CIN 80/6,315 (1.3) 116/20,969 (0.6) 2.30 (1.68 to 3.16) <0.001�
Treated CIN vs untreated CIN 80/6,315 (1.3) 32/3,940 (0.8) 1.72 (1.12 to 2.65) 0.01
Treated CIN�2× vs no CIN 9/321 (2.8) 116/20,969 (0.6) 5.32 (2.58 to 10.95) <0.001�
Treated CIN�2× vs untreated CIN 9/321 (2.8) 32/3,940 (0.8) 3.95 (1.82 to 8.61) <0.001�
Treated CIN�2× vs treated CIN 1× 9/321 (2.8) 71/5,994 (1.2) 2.47 (1.19 to 5.12) 0.02
Preterm birth <28 weeksb 85/31,224 (0.3)
Untreated CIN vs no CIN 12/3,940 (0.3) 41/20,969 (0.2) 1.22 (0.58 to 2.57) 0.60
Treated CIN vs no CIN 32/6,315 (0.5) 41/20,969 (0.2) 2.55 (1.50 to 4.35) 0.001�
Treated CIN vs untreated CIN 32/6,315 (0.5) 12/3,940 (0.3) 2.09 (0.99 to 4.40) 0.05
Treated CIN�2× vs no CIN <5/321 (<1.6)d 41/20,969 (0.2) 7.02 (2.35 to 21.02) <0.001�
Treated CIN�2× vs untreated CIN <5/321 (<1.6)d 12/3,940 (0.3) 5.72 (1.71 to 19.16) 0.005�
Treated CIN�2× vs treated CIN 1× <5/321 (<1.6)d 28/5,994 (0.5) 3.03 (1.01 to 9.09) 0.05
aWith adjustment for age at childbirth, year of childbirth, urbanization, ethnicity, diabetes mellitus, maternal infection, epilepsy, psychiatric diseases, history of abortion,
history of preterm birth, pregnancy by IVF, nulliparous women, pre-eclampsia, gestational diabetes, placental abruption, placenta or vasa previa, congenital diseases,
intrauterine growth restriction, macrosomia, stillbirth, and fetal distress.
bWomen with induction of labor were excluded from analysis.
cTo adjust for multiple testing, we considered a P value of <0.008 statistically significant.
dTo prevent revealing data, numbers of less than 5 are grouped together, conform the rules of CBS.
�Statistically significant.
Abbreviations: CBS, Statistics Netherlands; CI, confidence interval; CIN, cervical intraepithelial neoplasia; IVF, in vitro fertilization; NA, not applicable; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003665.t002
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0.54 day; 95% CI 0.30 to 0.77; P< 0.001. Control group excluded: 0.52 day; 95% CI 0.28 to
0.76; P< 0.001). In Table 3, we assessed if there was a cutoff value for volume from which the
risk shows a significant increase (unadjusted analyses in S3 Table). Independent from the
severity of cervical disease, an excised volume between 0.10 and 0.49 cc did not increase the
odds of preterm birth (OR 1.06; 95% CI 0.69 to 1.64; P = 0.79). However, a ±2 times increased
odds of preterm birth was seen from a volume of 0.50 cc (an excised volume of 0.50 to 0.99 cc:
Fig 2. Spontaneous births by gestational age per volume excised from cervix before each childbirth. The
distribution between the groups was statistically significantly different for 0 cc vs 1.00–3.99 cc (P< 0.001), 0 cc vs 4.00–
8.99 cc (P< 0.001), 0 cc vs�9 cc (P< 0.001), 0.10–0.49 cc vs 4.00–8.99 cc (P = 0.005), 0.10–0.49 cc vs�9 cc
(P = 0.004), 1.00–3.99 cc vs 4.00–8.99 cc (P = 0.005), 1.00–3.99 cc vs�9 cc (P = 0.008) (two-sample Kolmogorov–
Smirnov test). CIN, cervical intraepithelial neoplasia.
https://doi.org/10.1371/journal.pmed.1003665.g002
Table 3. Multivariable logistic regression for preterm birth per volume taken from the cervix before each
childbirtha.
Preterm birth <37 weeksb Events/total (%) OR (95% CI) P valuec
1,355/24,950 (5.4)
0.10–0.49 cc vs 0 cc 26/531 (4.9) 1,002/20,969 (4.8) 1.06 (0.69 to 1.64) 0.79
0.50–0.99 cc vs 0 cc 37/379 (9.8) 1,002/20,969 (4.8) 2.20 (1.52 to 3.20) <0.001�
1.00–3.99 cc vs 0 cc 170/2,208 (7.7) 1,002/20,969 (4.8) 1.70 (1.40 to 2.08) <0.001�
4.00–8.99 cc vs 0 cc 90/724 (12.4) 1,002/20,969 (4.8) 3.13 (2.44 to 4.01) <0.001�
�9 cc vs 0 cc 30/139 (21.6) 1,002/20,969 (4.8) 5.93 (3.86 to 9.13) <0.001�
aWith adjustment for age at childbirth, year of childbirth, urbanization, severity of cervical disease (normal, CIN1,
CIN2, or�CIN3), ethnicity, diabetes mellitus, maternal infection, epilepsy, psychiatric diseases, history of abortion,
history of preterm birth, pregnancy by IVF, nulliparous women, pre-eclampsia, gestational diabetes, placental
abruption, placenta or vasa previa, congenital diseases, intrauterine growth restriction, macrosomia, stillbirth, and
fetal distress.
bWomen with induction of labor were excluded from analysis.
cTo adjust for multiple testing, we considered a P value of <0.01 statistically significant.
�Statistically significant.
Abbreviations: CI, confidence interval; CIN, cervical intraepithelial neoplasia; IVF, in vitro fertilization; OR, odds
ratio.
https://doi.org/10.1371/journal.pmed.1003665.t003
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OR 2.20; 95% CI 1.52 to 3.20; P< 0.001; and an excised volume of 1.00 to 3.99 cc: OR 1.70;
95% CI 1.40 to 2.08; P< 0.001). These odds further increased for women with an excised vol-
ume of 4.00 to 8.99 cc (OR 3.13; 95% CI 2.44 to 4.01; P< 0.001) and�9.00 cc (OR 5.93; 95%
CI 3.86 to 9.13; P< 0.001). The other way around, we did not find a statistically significant dif-
ference in the odds of preterm birth in women with CIN1 or CIN2 compared to women with-
out CIN (OR 1.13; 95% CI 0.75 to 1.71; P = 0.57 and OR 1.30; 95% CI 1.02 to 1.67; P = 0.04,
respectively), or between women with CIN2 or�CIN3 compared to CIN1 (OR 1.11; 95% CI
0.70 to 1.74; P = 0.66 and OR 1.21; 95% CI 0.79 to 1.85; P = 0.39, respectively), when we
adjusted for the volume taken from the cervix (S4 Table). Only women with�CIN3 had a
greater odds of preterm birth compared to women without CIN independently from the vol-
ume excised from the cervix (OR 1.44; 95% CI 1.17 to 1.77; P< 0.001).
Maternal outcomes
In Table 4 and S5 Table, we show the maternal outcomes with the same group comparisons as
for our primary outcome. As expected, we found similar ORs for threatened preterm birth and
pPROM as we saw for preterm birth. There was no significant difference in odds for spontane-
ous conception between women with treated CIN compared to untreated CIN (OR 0.94; 95%
CI 0.81 to 1.09; P = 0.43). We found no statistically significant differences in the odds of assis-
ted vaginal delivery or cesarean section between all groups, beside a slightly higher odds for
assisted vaginal delivery in treated women compared to women without CIN (OR 1.18; 95%
CI 1.08 to 1.29; P< 0.001).
Neonatal outcomes
Neonatal outcomes are shown in Table 4 and S6 Table. Given the positive correlation
between gestational age and birth weight, similar ORs were found for low birth weight
(<2,500 grams) as for preterm birth. No statistically significant difference was found for
birth weight <2,000 grams for women with untreated CIN compared to women without
CIN (OR 1.50; 95% CI 1.08 to 2.08; P = 0.02) or treated CIN compared to untreated CIN
(OR 1.54; 95% CI 1.10 to 2.16; P = 0.01). The highest odds for birth weight <1,000 grams
was for women with multiple treatments compared to women without CIN (OR 8.30; 95%
CI 2.74 to 25.19; P< 0.001). The Hoftiezer percentiles show that there was no statistically
significant difference in the odds of small for gestational age. A low APGAR score and
intensive care admission rates were all increased in women with treated CIN compared to
women without CIN (OR 1.47; 95% CI 1.15 to 1.88; P = 0.002 and OR 1.56;95% CI 1.32 to




In this population-based study, including 45,259 pregnancy outcomes, we observe that both
women with untreated CIN and treated CIN have an increased odds of spontaneous preterm
birth compared to women without a CIN diagnosis. We also observe that an excised total vol-
ume of<0.5 cc of cervical tissue is not associated with preterm birth; however, a higher excised
volume is linked to a�2 times increase in odds of preterm birth, which seems independent
from the severity of the underlying cervical disease or other potential risk factors.
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Table 4. Multivariable logistic regression for maternal and neonatal outcomes for women with no CIN, untreated CIN, and treated CIN before each childbirtha.
Maternal outcomes
Event/total (%) OR (95% CI) P valuecAU : Pleasenotethattheindicatorshavebeenrearrangedalphabetically;movingdownwardinTable4;asperPLOSstyle; hence; thefootnoteshavebeenrearrangedaswell:Pleaseconfirmthatthesechangesarevalid:
Spontaneous conceptionb 27,938/30,087 (92.9)
Untreated CIN vs no CIN 3,710/4,017 (92.4) 18,336/19,668 (93.2) 1.27 (1.11 to 1.45) 0.001�
Treated CIN vs no CIN 5,892/6,402 (92.0) 18,336/19,668 (93.2) 1.19 (1.07 to 1.33) 0.002�
Treated CIN vs untreated CIN 5,892/6,402 (92.0) 3,710/4,017 (92.4) 0.94 (0.81 to 1.09) 0.43
Threatened preterm birth 1,247/45,259 (2.8)
Untreated CIN vs no CIN 192/5,940 (3.2) 659/29,907 (2.2) 1.53 (1.29 to 1.81) <0.001�
Treated CIN vs no CIN 396/9,412 (4.2) 659/29,907 (2.2) 2.08 (1.81 to 2.38) <0.001�
Treated CIN vs untreated CIN 396/9,412 (4.2) 192/5,940 (3.2) 1.36 (1.14 to 1.62) 0.001�
pPROMd 1,971/30,740 (6.4)
Untreated CIN vs no CIN 292/3,953 (7.4) 1,045/20,386 (5.1) 1.31 (1.13 to 1.51) <0.001�
Treated CIN vs no CIN 634/6,401 (9.9) 1,045/20,386 (5.1) 1.90 (1.70 to 2.12) <0.001�
Treated CIN vs untreated CIN 634/6,401 (9.9) 292/3,953 (7.4) 1.45 (1.25 to 1.67) <0.001�
Assisted vaginal delivery 3,941/44,556 (8.8)
Untreated CIN vs no CIN 556/5,832 (9.5) 2,453/29,482 (8.3) 1.04 (0.94 to 1.16) 0.42
Treated CIN vs no CIN 932/9,242 (10.1) 2,453/29,482 (8.3) 1.18 (1.08 to 1.29) <0.001�
Treated CIN vs untreated CIN 932/9,242 (10.1) 556/5,832 (9.5) 1.13 (1.01 to 1.27) 0.04
Cesarean sectione 3,640/44,157 (8.2)
Untreated CIN vs no CIN 518/5,777 (9.0) 2,343/29,231 (8.0) 0.94 (0.85 to 1.04) 0.23
Treated CIN vs no CIN 779/9,149 (8.5) 2,343/29,231 (8.0) 0.91 (0.83 to 0.99) 0.03
Treated CIN vs untreated CIN 779/9,149 (8.5) 518/5,777 (9.0) 0.97 (0.86 to 1.09) 0.55
Neonatal outcomes
Event/total (%) OR (95% CI) P valuec
Birth weight <2,500 gramsf 1,126/31,186 (3.6)
Untreated CIN vs no CIN 171/3,936 (4.3) 573/20,942 (2.7) 1.45 (1.20 to 1.76) <0.001�
Treated CIN vs no CIN 382/6,308 (6.1) 573/20,942 (2.7) 2.21 (1.91 to 2.56) <0.001�
Treated CIN vs untreated CIN 382/6,308 (6.1) 171/3,936 (4.3) 1.52 (1.25 to 1.85) <0.001�
Birth weight <1,500 gramsf 153/31,186 (0.5)
Untreated CIN vs no CIN 20/3,936 (0.5) 77/20,942 (0.4) 1.14 (0.66 to 1.95) 0.65
Treated CIN vs no CIN 56/6,308 (0.9) 77/20,942 (0.4) 2.32 (1.58 to 3.41) <0.001�
Treated CIN vs untreated CIN 56/6,308 (0.9) 20/3,936 (0.5) 2.04 (1.18 to 3.54) 0.01
Birth weight Hoftiezer percentile �2f 542/31,084 (1.7)
Untreated CIN vs no CIN 87/3,917 (2.2) 334/20,877 (1.6) 0.87 (0.66 to 1.13) 0.28
Treated CIN vs no CIN 121/6,290 (1.9) 334/20,877 (1.6) 1.03 (0.81 to 1.30) 0.83
Treated CIN vs untreated CIN 121/6,290 (1.9) 87/3,917 (2.2) 1.19 (0.88 to 1.60) 0.27
APGAR <7f 400/31,224 (1.3)
Untreated CIN vs no CIN 57/3,940 (1.4) 232/20,969 (1.1) 1.18 (0.87 to 1.61) 0.29
Treated CIN vs no CIN 111/6,315 (1.8) 232/20,969 (1.1) 1.47 (1.15 to 1.88) 0.002�
Treated CIN vs untreated CIN 111/6,315 (1.8) 57/3,940 (1.4) 1.24 (0.89 to 1.73) 0.20
NICU admissionf 827/31,224 (2.6)
Untreated CIN vs no CIN 104/3,940 (2.6) 480/20,969 (2.3) 1.03 (0.82 to 1.29) 0.79
Treated CIN vs no CIN 243/6,315 (3.8) 480/20,969 (2.3) 1.56 (1.32 to 1.85) <0.001�
Treated CIN vs untreated CIN 243/6,315 (3.8) 104/3,940 (2.6) 1.52 (1.19 to 1.93) 0.001�
Perinatal deathf,g 56/31,216 (0.2)
Untreated CIN vs no CIN <5/3,937 (<0.2)h 41/20,967 (0.2) 0.37 (0.11 to 1.20) 0.10
Treated CIN vs no CIN 11/6,312 (0.2) 41/20,967 (0.2) 0.64 (0.30 to 1.38) 0.25
(Continued)
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Treated women versus women without CIN
In our study, we observed that in women with treated CIN, the odds of preterm birth<37
weeks doubles as compared to healthy controls. The most recent Cochrane review showed a
comparable risk of preterm birth in treated women compared to an untreated external com-
parison group (risk ratio (RR) 1.97 [95% CI 1.71 to 2.26]) [5]. For preterm birth <32 and<28
weeks, they only compared excisional treatment to all women without treatment (RR 2.48
[95% CI 1.92 to 3.20] and RR 2.81 [95% CI 1.89 to 4.18], respectively), but results are overall
comparable with our findings. Only 2 large studies [12,13] and several smaller studies [14–25]
assessed the risk of spontaneous preterm birth, excluding women with premature induction of
labor, which is the actual outcome of interest. The same meta-analysis found a RR of 1.76
(95% CI 1.47 to 2.11) for spontaneous preterm birth in treated women versus women without
treatment [5]. Only 7 and 2 studies were assessed for preterm birth <32 and <28 weeks,
respectively, with increasing RRs in more severe preterm birth [5].
Treated women versus untreated women with CIN
Over the years, it has become more clear that not only women with excisional treatment of
CIN but also women with conservatively managed CIN may have an increased risk of adverse
perinatal outcomes. We observed an increased adjusted odds for preterm birth in treated
women versus untreated women with CIN. These increased odds remained statistically signifi-
cant with adjustment for severity of cervical disease but were no longer statistically significant
after adjustment for size of the excision. This is in line with the Cochrane review that found an
increased risk in women with untreated CIN compared to the general population [5]. How-
ever, 3 other meta-analyses found an increased, although not significant, risk of preterm birth
for women with treated CIN versus untreated CIN [3–5,7]. These findings raise the question
whether having cervical disease or underlying common risk factors are actually causing pre-
term birth. While some studies have found no association between treated CIN and preterm
birth after adjustment of potential confounders [23,25–27], our results remained significant
after adjustment for 19 potential confounding factors. These results suggest that the possible
correlation of preterm birth points to the excisional procedure itself (biopsy or treatment) and
not the underlying cervical disease.
Table 4. (Continued)
Treated CIN vs untreated CIN 11/6,312 (0.2) <5/3,937 (<0.2)h 1.74 (0.48 to 6.38) 0.40
aWith adjustment for age at childbirth, year of childbirth, urbanization, ethnicity, diabetes mellitus, maternal infection, epilepsy, psychiatric diseases, history of abortion,
history of preterm birth, pregnancy by IVF, nulliparous women, pre-eclampsia, gestational diabetes, placental abruption, placenta or vasa previa, congenital diseases,
intrauterine growth restriction, macrosomia, stillbirth, and fetal distress.
bAdjustment for pregnancy by IVF excluded.
cTo adjust for multiple testing, we considered a P value of <0.008 statistically significant.
dWomen with induction of labor with�36 hours of rupture of membranes were excluded from analysis.
eWomen with a primary cesarean section and women with the position of the baby being the indication for secondary cesarean section were excluded.
fWomen with induction of labor were excluded from analysis.
gPeriod defined as between 22 weeks of gestation and�28 days postpartum.
hTo prevent revealing data, numbers of less than 5 are grouped together, conform the rules of CBS.
�Statistically significant.
Abbreviations: APGAR, appearance, pulse, grimace, activity, and respiration; CBS, Statistics Netherlands; CI, confidence interval; CIN, cervical intraepithelial neoplasia;
IVF, in vitro fertilization; NICU, neonatal intensive care unit; pPROM, preterm premature rupture of membranes.
https://doi.org/10.1371/journal.pmed.1003665.t004
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Size of the excision
It seems logical that the risk of preterm birth depends on the excised cervical volume. We
observed that the turning point of an excision without increasing the odds of preterm birth
could be from 0.5 cc onwards. An excised size of�0.5 cc may arise from one large or multiple
smaller biopsies. Therefore, one should consider multiple biopsies with similar prudence as
the caution that is taken when performing an excisional treatment in fertile women. A meta-
analysis found a 2 times increased risk of preterm birth in women undergoing loop electrosur-
gical excision procedure (LEEP) with�10 to 12 mm depth [5]. This risk further increased
with increasing depth of the LEEP excision. A retrospective cohort study with 556 women
found an increased risk of preterm birth in both small-medium (�6 cc) and large (>6 cc)
LEEPs compared to untreated women [5,28]. Another retrospective cohort study with 321
women showed a 3-fold increased risk of preterm birth if the excised volume was >6 cc com-
pared to�6 cc [29], and a Norwegian population-based cohort study found a strong associa-
tion over time from >4 cc of excised volume [30]. In contrast, a Danish population-based
cohort study found an association between the depth, but not the volume, of the LEEP and the
gestational age at delivery [17].
Severity of cervical disease
While we observed that in our cohort the severity of CIN did not seem to be related to the
odds of preterm birth between untreated and treated women with CIN when adjusted for the
size of excision, an increased odds was seen between women with�CIN3 compared to
women without CIN (S4 Table). These increased odds were, however, not seen between
women with CIN1 or CIN2 compared to women without CIN. A retrospective cohort study
with 624 women also did not find an association between CIN severity and preterm birth [31].
A Finnish population-based cohort study found, beside an increased odds for preterm birth in
women with carcinoma in situ or microinvasive cancer, no increased odds with severity of
CIN [32]. However, they did not adjust for excision size. Additionally, the increased odds for
preterm birth was also seen in treated women with non-CIN lesions. This may implicate that
the severity of cervical disease may play a role in preterm birth, although only very minor.
Maternal outcomes
Compared to the most recent meta-analysis, we found similar findings for the association with
threatened preterm birth but a less strong association with pPROM (our study: treated CIN
versus no CIN OR 1.90; 95% CI 1.70 to 2.12; P< 0.001. Our study: treated CIN versus
untreated CIN OR 1.45; 95% CI 1.25 to 1.67; P< 0.001. Kyrgiou and colleagues: treated CIN
versus no/untreated CIN RR 2.15; 95% CI 1.48 to 3.12) [5]. However, we excluded women
with induction of labor with�36 hours of ruptured membranes. In line with this meta-analy-
sis, we found no association between assisted vaginal deliveries or cesarean sections and treat-
ment of CIN (besides assisted vaginal delivery in women with treated CIN versus no CIN: OR
1.18; 95% CI 1.08 to 1.16; P< 0.001).
Neonatal outcomes
The above mentioned meta-analysis showed also similar results for low birth weight [5]. Only
5 studies have outcomes on low birth weight <1,000 to 2,000 grams [17,33–36]. A retrospec-
tive cohort study found an increased risk for low birth weight and small for gestational age in
women treated for�CIN3 compared to women without CIN [37]. Our study shows that
women with treated CIN have a>2 times increased odds for low birth weight (<1,000,
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<1,500, <2,500, and<2,500 grams) compared to women without CIN. Our results suggest
that these increased odds for low birth weight may be independent of a relationship with small
for gestational age, since we found no association between Hoftiezer percentile�2 and treat-
ment for CIN (Table 4 and S6 Table). Only 2 studies assessed the outcome APGAR score <7
at 5 minutes and found no statistically significant relationship [15,38], while we found a 1.5
times statistically significant increased odds in women with treated CIN. A similar increased
odds was found in our study for high care and NICU admission and was comparable with the
literature [5]. Perinatal death was too rare in our study to give conclusive results, but the most
recent meta-analysis showed a 1.5 times increased risk for treated women compared to
untreated women [5].
Strengths and limitations
One of the strengths of our study is the use of a large population-based cohort, extracted from
validated national pathology and perinatal datasets with an almost complete nationwide cover-
age of all pathology and pregnancies. This leads to minimal reporting, recall, and selection
bias. Additionally, we included women and pregnancies over a long period of time.
For preterm birth, pPROM, and all neonatal outcomes, we only assessed women who had
spontaneous births or rupture of membranes. There are many reasons for premature induc-
tion of labor, and these might be caused by underlying communal factors. We also adjusted for
19 identified potential confounders for preterm birth, reducing the likelihood that the possible
correlation with preterm birth is just risk factors associated with cervical dysplasia.
We made appropriate comparison groups, by using frequency matching, and compared all
3 groups with each other: (1) women with untreated CIN versus controls; (2) women with
treated CIN versus controls; and (3) women with treated CIN versus women with untreated
CIN.
This study is unique in investigating associations of the volume of the excised cervical tissue
of both biopsies and treatments and the odds of preterm birth with adjustment for severity of
cervical disease and all other potential confounders. This gave us the opportunity to further
investigate possible associations of preterm birth in women with untreated CIN. We were able
to identify excision volumes for which there was an associated greater risk of preterm birth.
Limitations are the retrospective nature and the lack of information about smoking, sexual
behavior, and socioeconomic status. We were unable to adjust for these factors, which are
associated with both preterm birth and having CIN. However, by comparing untreated
women with treated women, these possible confounders can be considered to be similar across
these 2 groups.
We could not further distinct the type of excisional treatment, but the Dutch guidelines rec-
ommend treatment of high-grade CIN with LEEP [39]. Also, the excised volume could be cal-
culated for only a select group of women, as the macroscopic description was not always (in 3
dimensions) identifiable, which potentially could give selection bias. However, the adjusted
ORs of spontaneous preterm birth was not statistically significantly different between the
group with known and unknown excised volume, which reduces the chance of selection bias.
Furthermore, it should be kept in mind that cervical specimens are measured after formalin
fixation, which may have shrunk the specimens. Therefore, the effect of the excised volume on
the odds of preterm birth could be overestimated.
We could not find conclusive results on the odds of extreme premature birth <24 weeks,
due to incomplete registration of extreme premature nonviable births 16 to 24 weeks, which
are not mandatory to report with the municipality. This information was particularly needed
to link data of Perined with PALGA.
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Clinical practice and next steps for research
With the knowledge of high regression rates of CIN1 and CIN2, especially in young women,
and the increased risk for obstetrical complications after treatment, most guidelines are chang-
ing toward a more conservative approach for young women since 2012 [40,41]. However, see-
and-treat approach has also become more popular over the years, which could result in higher
overtreatment rates [42]. Additionally, hrHPV-based screening causes higher referral rates
and more women undergoing biopsy or treatment [6], resulting in more women at risk for
adverse pregnancy outcomes. With our finding that excisional procedure of both biopsy and
treatment from�0.5 cc was associated with increased odds of preterm birth, we should opti-
mize management of CIN in women of reproductive age. Women with a potential desire for
future pregnancy should be counseled properly about the harms and benefits of both biopsy
and excisional treatment. Moreover, once women with this increased risk of preterm birth
become pregnant, they might benefit from closer surveillance during pregnancy to improve
perinatal outcome. More studies are warranted to further investigate the role of excision of cer-
vical tissue combined with having cervical disease on the risk of preterm birth.
Conclusions
Both women with untreated CIN and treated CIN have an increased odds of spontaneous pre-
term birth compared to women without a CIN diagnosis. We observed that a volume of�0.5
cc excised cervical tissue was associated with preterm birth, independently from the severity of
the underlying cervical disease or other potential risk factors. Caution should be taken when
performing excisional treatment in women of reproductive age as well as prudence in case of
multiple biopsies. Women that had a cervical excisional procedure (biopsy or treatment) with
in total�0.5 cc excised tissue should be identified and offered close surveillance during
pregnancy.
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CIN, and treated CIN before each childbirth. aWith adjustment for age at childbirth, year of
childbirth, urbanization, ethnicity, diabetes mellitus, maternal infection, epilepsy, psychiatric
diseases, history of abortion, history of preterm birth, pregnancy by IVF, nulliparous women,
pre-eclampsia, gestational diabetes, placental abruption, placenta or vasa previa, congenital
diseases, intrauterine growth restriction, macrosomia, stillbirth, and fetal distress. bAdjustment
for pregnancy by IVF excluded. cWomen with induction of labor with�36 hours of rupture of
membranes were excluded from analysis. dWomen with a primary cesarean section and
women with the position of the baby being the indication for secondary cesarean section were
excluded. eTo adjust for multiple testing, we considered a P value of<0.008 statistically signifi-
cant. �Statistically significant. CI, confidence interval; CIN, cervical intraepithelial neoplasia;
IVF, in vitro fertilization; pPROM, preterm premature rupture of membranes.
(DOCX)
S6 Table. Logistic regression for neonatal outcomes for women no CIN, untreated CIN,
and treated CIN before each childbirth. aWith adjustment for age at childbirth, year of child-
birth, urbanization, ethnicity, diabetes mellitus, maternal infection, epilepsy, psychiatric dis-
eases, history of abortion, history of preterm birth, pregnancy by IVF, nulliparous women,
pre-eclampsia, gestational diabetes, placental abruption, placenta or vasa previa, congenital
diseases, intrauterine growth restriction, macrosomia, stillbirth, and fetal distress. bWomen
with induction of labor were excluded from analysis. cTo adjust for multiple testing, we con-
sidered a P value of<0.008 statistically significant. dTo prevent revealing data, numbers of less
than 5 are grouped together, conform the rules of CBS. �Statistically significant. APGAR,
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appearance, pulse, grimace, activity and respiration; CBS, Statistics Netherlands; CI, confi-
dence interval; CIN, cervical intraepithelial neoplasia; IVF, in vitro fertilization; NICU, neona-
tal intensive care unit.
(DOCX)
S1 Fig. Study flowchart. CIN, cervical intraepithelial neoplasia; PALGA, the nationwide net-
work and registry of histo- and cytopathology in the Netherlands; Perined, the Dutch perinatal
registry.
(TIF)
S2 Fig. Spontaneous births by gestational age for women with no CIN, untreated CIN, or
treated CIN before each childbirth. The distribution between all 3 groups was statistically sig-
nificantly different (all P< 0.001; two-sample Kolmogorov–Smirnov test). CIN, cervical
intraepithelial neoplasia.
(TIF)
S3 Fig. Spontaneous births by gestational age per severity of cervical disease before each
childbirth. The distribution between all 4 groups was statistically significantly different (Nor-
mal vs CIN1 (P = 0.04), normal vs CIN2 (P< 0.001), normal vs CIN3 (P< 0.001), CIN1 vs
CIN3 (P = 0.003)), except for CIN1 vs CIN2 (P = 0.11) and CIN1 vs�CIN3 (P = 0.49). (Two-
sample Kolmogorov–Smirnov test). CIN, cervical intraepithelial neoplasia.
(TIF)
S4 Fig. Spontaneous births by gestational age per severity of cervical disease (panels A–D) and
excised volume before each childbirth. The distribution between the groups was statistically
significantly different for 0.10–0.49 cc vs 4.00–8.99 cc for CIN1 (P = 0.01), 0.10–0.49 cc vs�9
cc for�CIN3 (P = 0.02), and 1.00–3.99 cc vs�9 cc for� CIN3 (P = 0.03) (two-sample Kolmo-
gorov–Smirnov test). CIN, cervical intraepithelial neoplasia.
(TIF)
S1 Protocol. The prospective analysis plan.
(DOCX)
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